Camurus AB (publ) logo

Camurus AB (publ)

SSE:CAMX.ST

Overview | Financials
Company Name Camurus AB (publ)
Symbol CAMX.ST
Currency SEK
Price 440
Market Cap 25,354,384,000
Dividend Yield 0%
52-week-range 197.6 - 599.5
Industry Biotechnology
Sector Healthcare
CEO Mr. Fredrik Tiberg
Website https://www.camurus.com

An error occurred while fetching data.

About Camurus AB (publ)

Camurus AB (publ), a pharmaceutical company, develops and commercializes medicines for severe and chronic conditions in Europe, Australia, the United States, Japan, and internationally. The company offers Buvidal, a buprenorphine injection for the treatment of opioid dependence; episil oral liquid, a medical device for the treatment of inflammatory and painful

Related Stocks

Synsam AB (publ) logo

Synsam AB (publ)

SYNSAM.ST

45.15 SEK

BioGaia AB (publ) logo

BioGaia AB (publ)

BIOG-B.ST

124.4 SEK

Biotage AB (publ) logo

Biotage AB (publ)

BIOT.ST

184.3 SEK

Swedencare AB (publ) logo

Swedencare AB (publ)

SECARE.ST

60.34 SEK

CellaVision AB (publ) logo

CellaVision AB (publ)

CEVI.ST

257 SEK

BICO Group AB (publ) logo

BICO Group AB (publ)

BICO.ST

45.4 SEK

Surgical Science Sweden AB (publ) logo

Surgical Science Sweden AB (publ)

SUS.ST

179.1 SEK

Xvivo Perfusion AB (publ) logo

Xvivo Perfusion AB (publ)

XVIVO.ST

282 SEK

BioArctic AB (publ) logo

BioArctic AB (publ)

BIOA-B.ST

227.8 SEK

Financials

Numbers are in millions USD

Numbers are in millions USD